Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 3,0613,080 of 20,252 grants

Active TRAINING, INDIVIDUAL
Elucidation of the molecular mechanisms of the RBM15-MKL1 fusion protein in acute megakaryoblastic leukemia
NATIONAL CANCER INSTITUTE Yale University United States 2023 – 2026

PROJECT SUMMARY/ABSTRACT Acute megakaryoblastic leukemia (AMKL) is a form of cancer most prevalent in children under four years old. Targeted AMKL-specific treatment options are li...

$501.9K
USD
Active RESEARCH CENTERS
Kaposi Sarcoma in the Era of ART in Africa Program (KEAAP)
NATIONAL CANCER INSTITUTE Lsu Health Sciences Center United States 2023 – 2028

There are currently over 1.2 million people in Zambia and 1.7 million in Tanzania who are living with HIV/AIDS. Concomitant to the HIV epidemic, there is a high incidence of HIV/AI...

$9.21M
USD
Active RESEARCH CENTERS
Admin Core
NATIONAL CANCER INSTITUTE Lsu Health Sciences Center United States 2023 – 2028

A multi-institutional, international, and integrated endeavor, the “KS in the Era of ART in Africa Program (KEAAP)” will leverage the research and training expertise of collaborati...

Active RESEARCH CENTERS
Project 1
NATIONAL CANCER INSTITUTE Lsu Health Sciences Center United States 2023 – 2028

Despite more than a decade of implementing universal access to antiretroviral therapy (ART) in sub-Saharan Africa (SSA), Kaposi’s sarcoma (KS) remains the most common malignancy in...

Active RESEARCH CENTERS
Project 2
NATIONAL CANCER INSTITUTE Lsu Health Sciences Center United States 2023 – 2028

HIV-associated Kaposi sarcoma (KS), also known as epidemic Kaposi sarcoma (EpKS), is a leading malignancy in sub-Saharan Africa (SSA). It is among the top 10 malignancies by incide...

Active RESEARCH CENTERS
Project 3
NATIONAL CANCER INSTITUTE Lsu Health Sciences Center United States 2023 – 2028

ABSTRACT Kaposi sarcoma (KS), an HIV/AIDS-associated malignancy, is one of the most prevalent cancers in people living with HIV-1 (PLWH) in sub-Saharan Africa (SSA). AIDS-associate...

Active RESEARCH CENTERS
Data Core
NATIONAL CANCER INSTITUTE Lsu Health Sciences Center United States 2023 – 2028

ABSTRACT The Data Management and Integration Core (DMIC) of the Kaposi Sarcoma (KS) in Era of Antiretroviral Therapy in Africa Program (KEAAP) is responsible for streamlining and c...

Active RESEARCH CENTERS
Developmental Core
NATIONAL CANCER INSTITUTE Lsu Health Sciences Center United States 2023 – 2028

ABSTRACT Human resource capacity building and training are urgently needed to establish a sustainable research enterprise that will improve prevention, diagnosis, connection to car...

Active TRAINING, INDIVIDUAL
Deciphering the functional role of recurrent PPP2R1A mutations on endometrial metastasis
NATIONAL CANCER INSTITUTE University of Michigan At Ann Arbor United States 2023 – 2026

Project Summary: Uterine serous carcinomas (USC), uterine carcinosarcomas (UCS), and leiomyosarcomas represent the most aggressive subtypes of uterine cancer and account for a disp...

$408.1K
USD
Active TRAINING, INDIVIDUAL
Molecular mechanism of membrane association of Bruton's Tyrosine Kinase
NATIONAL CANCER INSTITUTE Yale University United States 2023 – 2026

PROJECT SUMMARY The adaptive immune system is driven by the B Cell receptor (BCR) pathway, which triggers B cell differentiation and proliferation in response to antigen binding. A...

$457.6K
USD
Active TRAINING, INDIVIDUAL
Structural studies of metazoan origin licensing
NATIONAL CANCER INSTITUTE Yale University United States 2023 – 2026

Project Summary Developing effective cancer therapies remains a significant challenge due to the heterogeneity of tumor physiology, cytotoxicity towards non-cancer cells, and the e...

$476.9K
USD
Completed TRAINING, INDIVIDUAL
The role of the gut microbiome in ICB-induced anti-tumor response and toxicity
NATIONAL CANCER INSTITUTE University of Tx Md Anderson Can Ctr United States 2023 – 2024

PROJECT SUMMARY Immune checkpoint blockade (ICB) has transformed clinical oncology by inducing durable responses and increasing survival rates in many types of cancers, including m...

$660K
USD
Active TRAINING, INDIVIDUAL
Investigating splicing-derived antigens in the context of Rbm10-mutant lung adenocarcinoma
NATIONAL CANCER INSTITUTE Harvard Medical School United States 2023 – 2027

Project summary: The adaptive immune system can specifically recognize and kill cancer cells. Therapies that reinvigorate tumor-specific CD8 T cells cure a subset of patients with...

$526.9K
USD
Active TRAINING, INDIVIDUAL
Defining the role of persistent DNA bridges in tumor-intrinsic immune activation in hereditary breast and ovarian cancer
NATIONAL CANCER INSTITUTE Yale University United States 2023 – 2026

PROJECT SUMMARY Chromosome segregation errors such as persistent DNA bridges accelerate genome instability, a hallmark of cancer. These toxic DNA lesions occur at a higher frequenc...

$466.6K
USD
Active TRAINING, INDIVIDUAL
Text-messaging Communication Micro-Intervention for Couples Coping with Advanced GI Cancer
NATIONAL CANCER INSTITUTE Duke University United States 2023 – 2026

A cancer diagnosis requires patients and their intimate partners to communicate effectively to navigate illness- related challenges. Research indicates that couples who use effecti...

$704.3K
USD
Active TRAINING, INDIVIDUAL
Dissecting Early Tumor Evolution to Uncover Mechanisms of Tumor Initiation and Drug Resistance
NATIONAL CANCER INSTITUTE University of California, San Francisco United States 2023 – 2027

PROJECT SUMMARY/ABSTRACT Despite the prevalence of prostate cancer worldwide, we lack an understanding of the genetic events that drive tumor initiation or drug resistance. Only a...

$398K
USD
Completed NON-SBIR/STTR RPGS
Targeting pancreatic cancer's metabolic addiction to HuR
NATIONAL CANCER INSTITUTE Case Western Reserve University United States 2023 – 2025

Pancreatic ductal adenocarcinoma (PDA) is the 3rd leading cause of cancer death in the U.S. and is generally refractory to chemotherapy. We discovered that the harsh PDA microenvir...

$4.32M
USD
Active OTHER RESEARCH-RELATED
Generating Research Opportunities Within Statistics at Fred Hutch (GROWS@FredHutch)
NATIONAL CANCER INSTITUTE Fred Hutchinson Cancer Center United States 2023 – 2028

Project Summary/Abstract In cancer research, the need for a diverse pool of researchers in statistics and data science has never been greater. Yet, the requisite academic pipeline...

$2.19M
USD
Active RESEARCH CENTERS
DF/HCC Prostate SPORE
NATIONAL CANCER INSTITUTE Dana-Farber Cancer Inst United States 2023 – 2028

PROJECT SUMMARY – OVERALL The Dana-Farber/Harvard Cancer Center (DF/HCC) Prostate SPORE seeks to improve the understanding and treatment of prostate cancer using a highly translati...

$25.86M
USD
Active RESEARCH CENTERS
DF/HCC Prostate SPORE
NATIONAL CANCER INSTITUTE Dana-Farber Cancer Inst United States 2023 – 2028

PROJECT SUMMARY – ADMINISTRATIVE CORE (CORE A) The DF/HCC Prostate SPORE Administrative Core (Core A) is instrumental for the overall function and success of the Prostate SPORE pro...